Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0973
Bid (Size) 0.0970 (13)
Ask (Size) 0.0984 (2)
Prev. Close 0.0973
Today's Range 0.0973 - 0.0973
52wk Range 0.0943 - 0.1580
Shares Outstanding 979,949,668
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
Via ACCESS Newswire
News headline image
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
Via ACCESS Newswire

Performance

YTD
-29.6%
-29.6%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-19.7%
-19.7%

More News

Read More
News headline image
Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
Via ACCESS Newswire
News headline image
Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
Via ACCESS Newswire
News headline image
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Via ACCESS Newswire
News headline image
Zomedica Corp. Announces Transition to OTCQB Venture Market
Via ACCESS Newswire
News headline image
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Via ACCESS Newswire
News headline image
Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
Via ACCESS Newswire
News headline image
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
Via ACCESS Newswire
News headline image
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
Via ACCESS Newswire
News headline image
Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents
Via ACCESS Newswire
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging
Via ACCESS Newswire
News headline image
Zomedica and UXR Announce Expanded Distribution Agreement in Canada
Via ACCESS Newswire
News headline image
Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio
Via ACCESS Newswire
News headline image
Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices
Via ACCESS Newswire
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine
Via ACCESS Newswire
News headline image
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Via ACCESS Newswire
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets
Via ACCESS Newswire
News headline image
Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala
Via ACCESS Newswire
News headline image
Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope
Via ACCESS Newswire
News headline image
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics
Via ACCESS Newswire
News headline image
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
Via ACCESS Newswire
News headline image
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations
Via ACCESS Newswire
News headline image
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
Via ACCESS Newswire
News headline image
Earnings Scheduled For March 13, 2025 ↗
Via Benzinga

Frequently Asked Questions

Is Zomedica Corp. Common Shares publicly traded?
Yes, Zomedica Corp. Common Shares is publicly traded.
What exchange does Zomedica Corp. Common Shares trade on?
Zomedica Corp. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Zomedica Corp. Common Shares?
The ticker symbol for Zomedica Corp. Common Shares is ZOM on the New York Stock Exchange
What is the current price of Zomedica Corp. Common Shares?
The current price of Zomedica Corp. Common Shares is 0.0973
When was Zomedica Corp. Common Shares last traded?
The last trade of Zomedica Corp. Common Shares was at 03/04/25 08:00 PM ET
What is the market capitalization of Zomedica Corp. Common Shares?
The market capitalization of Zomedica Corp. Common Shares is 95.35M
How many shares of Zomedica Corp. Common Shares are outstanding?
Zomedica Corp. Common Shares has 95M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.